A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma

Advanced adenocarcinoma of the pancreas has a very poor prognosis. The aim of this study was to assess the efficacy and tolerability of a combination of the chemotherapeutic agents gemcitabine and raltitrexed. Chemonaïve patients with advanced adenocarcinoma of the pancreas were treated with a combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arends, J J, Sleeboom, H P, Leys, M B L, ten Bokkel Huinink, D, de Jong, R S, Smit, J M, Nortier, J W R, Tesselaar, M E T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362068/
https://www.ncbi.nlm.nih.gov/pubmed/15668704
http://dx.doi.org/10.1038/sj.bjc.6602368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362068/
https://www.ncbi.nlm.nih.gov/pubmed/15668704
http://dx.doi.org/10.1038/sj.bjc.6602368

Ejemplares similares